Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Gastroenterology. 2018 Jun 30;155(4):1098–1108.e9. doi: 10.1053/j.gastro.2018.06.046

Figure 2.

Figure 2

Kaplan-Meier survival plot of the probability of remaining relapse free during the maintenance period (week 0 – 32) and being in remission at week 32 following randomization (week 48 of the trial). 84 patients in steroid-free response to open label MTX 25 mg/week after a 16-week induction period with a 12-week steroid taper were randomized to placebo or continuing MTX therapy (25 mg/week) for 32 weeks.